Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 2/20 | 0.45 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.43 |
| ▸ | NAAA | Q02083 | 2/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 2/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | MMP2 | P08253 | 2/20 | 0.33 |
| ▸ | MMP9 | P14780 | 2/20 | 0.33 |
| ▸ | LTA4H | P09960 | 1/20 | 0.33 |
| ▸ | ANPEP | P15144 | 1/20 | 0.33 |
| ▸ | LAP3 | P28838 | 1/20 | 0.33 |
| ▸ | NPEPPS | P55786 | 1/20 | 0.33 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.33 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16467209 | 0.98 | CYP19A1 (0.43) | CYP19A1EPHX1NAAAL3MBTL1HTT | |
| SCHEMBL13113342 | 0.86 | CYP19A1 (0.45) | CYP19A1EPHX1NAAAL3MBTL1HTT | |
| SCHEMBL27587439 | 0.81 | CYP19A1 (0.47) | CYP19A1EPHX1NAAAL3MBTL1HTT | |
| SCHEMBL786258 | 0.81 | EPHX1 (0.50) | CYP19A1EPHX1NAAAL3MBTL1HTT | |
| SCHEMBL14987803 | 0.80 | CYP19A1 (0.46) | CYP19A1EPHX1NAAAL3MBTL1HTT | |
| SCHEMBL14987801 | 0.80 | CYP19A1 (0.46) | CYP19A1EPHX1NAAAL3MBTL1HTT | |
| SCHEMBL18346675 | 0.80 | CYP19A1 (0.46) | CYP19A1EPHX1NAAAL3MBTL1HTT | |
| SCHEMBL22652326 | 0.80 | CYP19A1 (0.46) | CYP19A1EPHX1NAAAL3MBTL1HTT | |
| SCHEMBL878503 | 0.80 | TSHR (0.37) | EPHX1HTTRAB9ASMN1; SMN2ALDH1A1 | |
| SCHEMBL7223651 | 0.80 | CYP19A1 (0.46) | CYP19A1EPHX1NAAAL3MBTL1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150119604-A1 | METHOD FOR PRODUCING BETA-ALKOXYPROPIONAMIDE | IDEMITSU KOSAN CO., LTD. (JP) | 2015-04-30 | — | — | US | disclosed |
| EP-2837619-A1 | METHOD FOR PRODUCING BETA -ALKOXYPROPIONAMIDE | Idemitsu Kosan Co., Ltd (JP) | 2015-02-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150119604-A1 | METHOD FOR PRODUCING BETA-ALKOXYPROPIONAMIDE | HACL2, APEH, NAAA | CYP19A1 125/4885EPHX1 457/4885NAAA 3/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.